The interaction between PD-1 on T cells and PD-L1 on GBM and myeloid cells, in addition to the competition between CTLA-4 and T cell activating receptor CD28 for B71 and B72 on APC, produce inhibitory signals to exhaust T cells. Here, CD86 is linked to glioblastoma.